European ScreeningPort selects IDBS’ ActivityBase

By Staff reporter

- Last updated on GMT

Related tags Scientific method

European ScreeningPort is using IDBS’ ActivityBase XE to manage growing demand for screening services from the academic institutes which outsource to it.

Use of ActivityBase, which is used by pharma companies, helps fulfil European ScreeningPort’s goal of providing academia with the services needed to transfer their research to industry.

Sheraz Gul, vice president and head of biology at European ScreeningPort, explained that ActivityBase ensures appropriate data integrity and its use in industry gives the organisation credibility.

European ScreeningPort will use the system to capture, visualise, analyse, quality check and verify data generated by plate-based screening. IDBS believes performing these tasks in the same environment streamlines workflow and optimises productivity.

Neil Kipling, founder and CEO of IDBS, added: "Working with European ScreeningPort, IDBS is providing a platform for effective scientific collaboration between academic research and the pharmaceutical industry, enabling a unique network of partners to combine their scientific knowledge, technical expertise and industry experience​."

European ScreeningPort’s development

Addition of the technology is the latest step in the growth of Germany-based European ScreeningPort, which was established in 2007 to provide academic institutes with pharma industry standard services.

Evotec was involved in setting up the public-private partnership. Since launching European ScreeningPort has provided academic partners, including Helmholtz Research Society and Max Planck organisations, with an array of small molecule screening services.

These give organisations access to automated molecular screening platforms, bioinformatics knowledge, chemical and biological infrastructure and staff with substantial pharmaceutical industry experience.

Related news

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

When Every Day Counts

When Every Day Counts

Content provided by Saama | 25-Oct-2023 | Case Study

While developing a vaccine for COVID-19, a Top 3 pharmaceutical company had an urgent need

Related suppliers

Follow us

Products

View more

Webinars